4.6 Article

Gene Set Enrichment Analsyes Identiify Pathways Involved in Genetic Risk for Diabetic Retinopathy

期刊

AMERICAN JOURNAL OF OPHTHALMOLOGY
卷 233, 期 -, 页码 111-123

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajo.2021.06.014

关键词

-

资金

  1. Research to Prevent Blindness, Inc, New York
  2. National Eye Institute [EY16335, EY22302, EY11753, R01 EY023644, EY001792, ZIAEY00401]
  3. Massachusetts Lions Eye Research Fund
  4. Alcon Research Institute
  5. American Diabetes Association [1-11-CT-51]
  6. Harvard Catalyst
  7. U.S. National Institutes of Health (NIH) [ZIAAG007380]
  8. NIH [N01-AG-1-2100, 5RC2HL102419, HHSC268200782096C, R01 DK087914, R01 DK066358, R01 DK053591, DK070941, DK084149]
  9. Hjartavernd (the Icelandic Heart Association)
  10. Althingi (Icelandic Parliament)
  11. University of Iceland Research Fund
  12. National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367, R01HL086694]
  13. National Human Genome Research Institute [U01HG004402]
  14. National Institutes of Health [HHSN268200625226C]
  15. NHLBI
  16. NIH
  17. Department of Health and Human Services [HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700004I, HHSN268201700005I]
  18. National Health and Medical Research Council (NHMRC) of Australia [595918]
  19. Ophthalmic Research Institute of Australia
  20. NHMRC
  21. Australian NHMRC
  22. Canberra Australia (NHMRC) [974159, 211069, 302068, 512423, 475604, 529912]
  23. Centre for Clinical Research Excellence in Translational Clinical Research in Eye Diseases
  24. CCRE in TCR-Eye [529923]
  25. Wellcome Trust, UK, as part of Wellcome Trust Case Control Consortium 2 [085475/B/08/Z, 085475/08/Z]
  26. NHLBI [U01HL080295, U01HL130114, HHSN268201300046C, HHSN268201300047C, N02-HL-64278, U01HL065520, U01HL041654, U01HL041652]
  27. National Institute on Aging [R01AG023629]
  28. Jackson Heart Study (JHS) [HHSN268201300049C, HHSN268201300050C]
  29. Tougaloo College [HHSN268201300048C]
  30. National Institute for Minority Health and Health Disparities
  31. Intramural Research Program of the National Eye Institute [ZIAEY000403]
  32. Wake Forest School of Medicine [M01 RR07122]
  33. Venture Fund
  34. National Eye Institute of the NIH [EY014684]
  35. ARRA Supplement [EY014684-03S1,-04S1]
  36. National Institute of Diabetes and Digestive and Kidney Disease [DK063491]
  37. Eye Birth Defects Foundation Inc.
  38. National Center for Advancing Translational Sciences
  39. CTSI [UL1TR001881]
  40. National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center [DK063491]
  41. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U01DK57292, U01DK57329, U01DK057300, U01DK057298, U01DK057249, U01DK57295, U01DK070657, U01DK057303, U01DK57304]
  42. Intramural Research Program of the NIDDK
  43. National Cancer Institute, NIH [N01-CO-12400]
  44. Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research
  45. National Center for Research Resources for the General Clinical Research Center [M01-RR-000080]
  46. WFU [M01-RR-07122]
  47. Harbor-University of California
  48. Los Angeles Medical Center [M01-RR-00425]
  49. College of Medicine, University of California, Irvine [M01-RR-00827-29)]
  50. University of New Mexico [HSC M01-RR-00997]
  51. Frederic C. Bartter [M01-RR-01346]
  52. [UL1RR025005]
  53. [HHSN268201200036C]
  54. [HHSN268200800007C]
  55. [HHSN268201800001C]
  56. [N01HC55222]
  57. [N01HC85079]
  58. [N01HC85080]
  59. [N01HC85081]
  60. [N01HC85082]
  61. [N01HC85083]
  62. [N01HC85086]
  63. [N01HC75150]
  64. [75N92020D00001]
  65. [HHSN268201500003I]
  66. [N01-HC-95159]
  67. [75N92020D00005]
  68. [N01-HC-95160]
  69. [75N92020D00002]
  70. [N01-HC-95161]
  71. [75N92020D00003]
  72. [N01-HC-95162]
  73. [75N92020D00006]
  74. [N01-HC-95163]
  75. [75N92020D00004]
  76. [N01-HC-95164]
  77. [75N92020D00007]
  78. [N01-HC-95165]
  79. [N01-HC-95166]
  80. [N01-HC-95167]
  81. [N01-HC-95168]
  82. [N01-HC-95169]
  83. [UL1-TR-000040]
  84. [UL1-TR-001079]
  85. [UL1-TR-001420]
  86. [UL1-TR-001881]

向作者/读者索取更多资源

This study identified functionally related genes associated with diabetic retinopathy risk using gene set enrichment analyses in genome-wide association study meta-analyses. The variants in genes involved in oxidative stress, lipid transport and catabolism, and cell degeneration were found to be enriched for genes associated with DR risk.
PURPOSE: To identify functionally related genes associated with diabetic retinopathy (DR) risk using gene set enrichment analyses applied to genome-wide association study meta-analyses. METHODS: We analyzed DR GWAS meta-analyses performed on 3246 Europeans and 2611 African Ameri-cans with type 2 diabetes. Gene sets relevant to 5 key DR pathophysiology processes were investigated: tissue injury, vascular events, metabolic events and glial dys-regulation, neuronal dysfunction, and inflammation. Key-words relevant to these processes were queried in 4 path-way and ontology databases. Two GSEA methods, Meta-Analysis Gene set Enrichment of variaNT Associations (MAGENTA) and Multi-marker Analysis of GenoMic Annotation (MAGMA), were used. Gene sets were de-fined to be enriched for gene associations with DR if the P value corrected for multiple testing (Pcorr) was < .05. RESULTS: Five gene sets were significantly enriched for numerous modest genetic associations with DR in one method (MAGENTA or MAGMA) and also at least nominally significant (uncorrected P < .05) in the other method. These pathways were regula-tion of the lipid catabolic process (2-fold enrichment, Pcorr = .014); nitric oxide biosynthesis (1.92-fold en-richment, Pcorr = .022); lipid digestion, mobilization, and transport (1.6-fold enrichment, P = .032); apoptosis (1.53-fold enrichment, P = .041); and retinal ganglion cell degeneration (2-fold enrichment, Pcorr = .049). The interferon gamma (IFNG) gene, previously implicated in DR by protein-protein interactions in our GWAS, was among the top ranked genes in the nitric oxide pathway (best variant P = .0001). CONCLUSIONS: These GSEA indicate that variants in genes involved in oxidative stress, lipid transport and catabolism, and cell degeneration are enriched for genes associated with DR risk. (C) 2021 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据